Sanjeev Munshi

Chief Executive Officer @ EPOK Therapeutics

About

Specialties: Drug discovery & development; Business Development healthcare - licensing, Search & Evaluation, transactions; investments - new opportunities, company creation.

Country

United States

City

Chapel Hill

Industry

Pharmaceuticals

Skill

Lifesciences, Biotechnology

Experience

Chief Executive Officer

EPOK Therapeutics

2024-12 - Present · 1 yr 10 mos

Chief Business Officer

EPOK Therapeutics

2024-6 - Present · 2 yrs 4 mos

EIR

Eshelman Innovation

2023-11 - 2025-10 · 2 yrs

Chapel Hill, North Carolina, United States

Chief Business Officer

MGFB Bio

2022-9 - 2023-12 · 1 yr 4 mos

An oncology focussed company based on a novel technology platform licensed from Mayo Clinic.

Chief Business Officer

Greenfire Bio

2020-11 - 2023-12 · 3 yrs 2 mos

Advancing GRN-300, a novel SIK2/3 selective inhibitor for treating a number of cancer indications; Initial indication platinum resistant ovarian cancer; Ph-1 dose escalation on going.

Senior Vice President BD and Alliance Management

AlphaMeld Corporation

2020-2 - 2020-11 · 10 mos

Executive Director, Business Development and Licensing

Merck

2010-8 - 2020-1 · 9 yrs 6 mos

Chapel Hill, North Carolina

Search & Evaluation lead for Cardio-metabolic diseases, Ophthalmology and Women's health.

Director, Global Structural Biology

Merck

1995-12 - 2010-7 · 14 yrs 8 mos

Director

Merck Research Laboratories

2005 - 2010-7 · 5 yrs

Headed the structural biology department at West Point from 2005-2009; prosecuted projects across several different therapeutic areas including Oncology, Neuroscience, Antivirals; managed a team of up to 22 Ph.D. and non Ph.D. scientists. 2009 to 2010 headed the biophysics group focused on fragment based hit discovery.